Mechanisms of the immunosuppressive effects of mouse adipose tissue-derived mesenchymal stromal cells on mouse alloreactively stimulated spleen cells

Experimental and Therapeutic Medicine

Volumn 7, Issue 1, 2013, Pages 17-22

  Nagaya, Ryo ^a   Mizuno Kamiya, Masako ^a   Takayama, Eiji ^a   Kawaki, Harumi ^a   Onoe, Ippei ^a   Tanabe, Toshiichiro ^a   Nagahara, Kuniteru ^a   Kondoh, Nobuo ^a  

^a ASAHI UNIVERSITY   (Japan)

Author keywords

2 microglobulin; Adipose tissue derived stromal cells; Immunosuppression; Interferon

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SMALL INTERFERING RNA;

ADIPOGENESIS; ADIPOSE TISSUE; ALLOIMMUNITY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CONTACT; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; MALE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; OSTEOBLAST; POLYMERASE CHAIN REACTION; SPLEEN CELL;

EID: 84887880378     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1382     Document Type: Article

References (33)

1. Friedenstein AJ, Gorskaja JF and Kulagina NN: Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4: 267-274, 1976.
2. Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74, 1997.
3. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP and Hedrick MH: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228, 2001.
4. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE and Kanhai HH: Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22: 1338-1345, 2004.
5. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, NoortWA, Claas FH, Willemze R, Fibbe WE and Kanhai HH: Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102: 1548-1549, 2003.
6. In 't Anker PS, Noort WA, Scherjon SA, Kleijburg-van der Keur C, Kruisselbrink AB, van Bezooijen RL, Beekhuizen W, WillemzeR, Kanhai HH and Fibbe WE: Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88: 845-852, 2003.
7. Fraser JK, Schreiber R, Strem B, Zhu M, Alfonso Z, Wulur I and Hedrick MH: Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes. Nat Clin Pract Cardiovasc Med 3 (Suppl 1): S33-S37, 2006.
8. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE and Ringdén O: Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol57:11-20, 2003.
9. Potian JA, Aviv H, Ponzio NM, Harrison JS and RameshwarP: Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171: 3426-3434, 2003.
10. Tse WT, Pendleton JD, Beyer WM, Egalka MC and Guinan EC: Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75: 389-397, 2003.
11. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S and Gianni AM: Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843, 2002.
12. Plumas J, Chaperot L, Richard MJ, Molens JP, Bensa JC and Favrot MC: Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia 19: 1597-1604, 2005.
13. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noël D and Jorgensen C: Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102: 3837-3844, 2003.
14. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V and Uccelli A: Human mesenchymal stem cells modulate B-cell functions. Blood 107: 367-372, 2006.
15. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC and Moretta L: Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111: 1327-1333, 2008.
16. + regulatory T cells. Clin Exp Immunol 156: 149-160, 2009.
17. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, HassanM, Uzunel M and Ringdén O: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441, 2004.
18. Hoogduijn MJ, Popp FC, Grohnert A, Crop MJ, van Rhijn M, Rowshani AT, Eggenhofer E, Renner P, Reinders ME, RabelinkTJ, van der Laan LJ, Dor FJ, Ijzermans JN, GeneverPG, Lange C, Durrbach A, Houtgraaf JH, Christ B, Seifert M, ShagidulinM, Donckier V, Deans R, Ringden O, Perico N, Remuzzi G, Bartholomew A, Schlitt HJ, Weimar W, BaanCC and Dahlke MH; MISOT Study Group: Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). Transplantation 90: 124-126, 2010.
19. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, LewisI, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W and RingdénO; Development Committee of the Eurpoean Group for Blood and Marrow Transplantation: Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371: 1579-1586, 2008.
20. Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, AvanziniMA, Ubezio C, Minelli A, Alvisi C, Vanoli A, CalliadaF, Dionigi P, Perotti C, Locatelli F and CorazzaGR: Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 60: 788-798, 2011.
21. Tse WT, Pendleton JD, Beyer WM, Egalka MC and GuinanEC: Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75: 389-397, 2003.
22. Melief SM, Zwaginga JJ, Fibbe WE and Roelofs H: Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med 2: 455-463, 2013.
23. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, DouglasR, Mosca JD, Moorman MA, Simonetti DW, Craig S and MarshakDR: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999.
24. Kondoh N, Ishikawa T, Ohkura S, Arai M, Hada A, Yamazaki Y, Kitagawa Y, Shindoh M, Takahashi M, Ando T, Sato Y, IzumoT, Hitomi K and Yamamoto M: Gene expression signatures that classify the mode of invasion of primary oral squamous cell carcinomas. Mol Carcinog 47: 744-756, 2008.
25. Lim JY, Park MJ, Im KI, Kim N, Jeon EJ, Kim EJ, Cho ML and Cho SG: Combination cell therapy using mesenchymal stem cells and regulatory T cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of Th1/Th2 and Th17/Treg cells in a murine acute graft-versus-host disease model. Cell Transplant: Feb 26, 2013 (Epub ahead of print).
26. Schroder K, Hertzog PJ, Ravasi T and Hume DA: Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189, 2004.
27. Cambiaggi C, Scupoli MT, Cestari T, Gerosa F, Carra G, Tridente G and Accolla RS: Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12. Immunogenetics 36: 117-120, 1992.
28. Yang HM, Sung JH, Choi YS, Lee HJ, Roh CR, Kim J, ShinM, Song S, Kwon CH, Joh JW and Kim SJ: Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression. Cytotherapy 14: 70-79, 2012.
29. Nasef A, Mathieu N, Chapel A, Frick J, François S, MazurierC, Boutarfa A, Bouchet S, Gorin NC, Thierry D and FouillardL: Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 84: 231-237, 2007.
30. Alberts B, Johnson A, Lewis J, Raff M, Roberts K and WalterP: T cells and MHC proteins. In: Molecular biology of the cell. 5th edition. Garland Science, New York, NY, pp1569-1588, 2008.
31. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K and Ozawa K: Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109: 228-234, 2007.
32. Yang HM, Sung JH, Choi YS, Lee HJ, Roh CR, Kim J, ShinM, Song S, Kwon CH, Joh JW and Kim SJ: Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression. Cytotherapy 14: 70-79, 2012.
33. Musso A, Zocchi MR and Poggi A: Relevance of the mevalonate biosynthetic pathway in the regulation of bone marrow mesenchymal stromal cell-mediated effects on T-cell proliferation and B-cell survival. Haematologica 96: 16-23, 2011.